MedPath

Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Dietary Supplement: Phaseolus Vulgaris
Dietary Supplement: Placebo
Registration Number
NCT05451927
Lead Sponsor
Hafiza Aisha Sadiqa
Brief Summary

This double-blind randomized placebo-controlled trial will test the hypothesis that administration of Phaseolus Vulgaris supplementation to women in Lahore, Pakistan, who are overweight will induce the weight loss (Primary outcome) and changes in body composition (Waist circumference) secondary outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
72
Inclusion Criteria
  • BMI ranges from 25-40
  • Consistently stable body weight for at least 6 months
  • Good general health
  • No ongoing drug treatment for weight reduction
  • Commitment to avoid any changes in lifestyle throughout the test period
  • Age between 18-45 years
  • Women resident of Lahore
Exclusion Criteria
  • Pregnant or breast-feeding females
  • People with Type 2 diabetes
  • People with any other chronic diseases
  • Weight reduction treatment during the 6 months prior to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Phaseolus VulgarisPhaseolus VulgarisThree oral doses of 1000 mg Phaseolus Vulgaris daily for 3 months
PlaceboPlaceboThree oral doses of Placebo daily for 3 months
Primary Outcome Measures
NameTimeMethod
Body weight3 months

change in body weight

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Akhuwat Medical Centre

🇵🇰

Lahore, Punjab, Pakistan

Niazi Medical Centre

🇵🇰

Lahore, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath